angiotensin ii has been researched along with Graves Ophthalmopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moini, M; Owji, N; Sagheb, MM | 1 |
1 other study(ies) available for angiotensin ii and Graves Ophthalmopathy
| Article | Year |
|---|---|
Potential benefit of angiotensin converting enzyme inhibitors for hindering progression of Graves' ophthalmopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cytokines; Disease Progression; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Models, Biological; Models, Theoretical; Transforming Growth Factor beta; Treatment Outcome | 2008 |